Drug Type Recombinant polypeptide, Biosimilar |
Synonyms- |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Fractures, Bone | EU | 12 Jan 2023 | |
Fractures, Bone | IS | 12 Jan 2023 | |
Fractures, Bone | LI | 12 Jan 2023 | |
Fractures, Bone | NO | 12 Jan 2023 | |
Glucocorticoid-induced osteoporosis | EU | 12 Jan 2023 | |
Glucocorticoid-induced osteoporosis | IS | 12 Jan 2023 | |
Glucocorticoid-induced osteoporosis | LI | 12 Jan 2023 | |
Glucocorticoid-induced osteoporosis | NO | 12 Jan 2023 | |
Osteoporosis, Postmenopausal | EU | 12 Jan 2023 | |
Osteoporosis, Postmenopausal | IS | 12 Jan 2023 | |
Osteoporosis, Postmenopausal | LI | 12 Jan 2023 | |
Osteoporosis, Postmenopausal | NO | 12 Jan 2023 |